BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21533575)

  • 1. Diffuse intrinsic pontine glioma-current status and future strategies.
    Khatua S; Moore KR; Vats TS; Kestle JR
    Childs Nerv Syst; 2011 Sep; 27(9):1391-7. PubMed ID: 21533575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse intrinsic pontine glioma: time for therapeutic optimism.
    Khatua S; Zaky W
    CNS Oncol; 2014; 3(5):337-48. PubMed ID: 25363006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of diffuse pontine gliomas in children: recent developments.
    Kebudi R; Cakir FB
    Paediatr Drugs; 2013 Oct; 15(5):351-62. PubMed ID: 23719782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.
    Infinger LK; Stevenson CB
    Curr Neuropharmacol; 2017; 15(1):129-133. PubMed ID: 27109746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse intrinsic pontine gliomas: treatments and controversies.
    Bredlau AL; Korones DN
    Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
    Hennika T; Becher OJ
    J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas.
    Hashizume R; Gupta N
    Curr Neuropharmacol; 2017; 15(1):98-103. PubMed ID: 27212051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse intrinsic pontine glioma: a reassessment.
    Robison NJ; Kieran MW
    J Neurooncol; 2014 Aug; 119(1):7-15. PubMed ID: 24792486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
    Hashizume R; Smirnov I; Liu S; Phillips JJ; Hyer J; McKnight TR; Wendland M; Prados M; Banerjee A; Nicolaides T; Mueller S; James CD; Gupta N
    J Neurooncol; 2012 Dec; 110(3):305-13. PubMed ID: 22983601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.
    Bredlau AL; Dixit S; Chen C; Broome AM
    Curr Neuropharmacol; 2017; 15(1):104-115. PubMed ID: 26903150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
    Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
    J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas.
    Sufit A; Donson AM; Birks DK; Knipstein JA; Fenton LZ; Jedlicka P; Hankinson TC; Handler MH; Foreman NK
    J Neurosurg Pediatr; 2012 Aug; 10(2):81-8. PubMed ID: 22747092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifty years of DIPG: looking at the future with hope.
    Tosi U; Souweidane M
    Childs Nerv Syst; 2023 Oct; 39(10):2675-2686. PubMed ID: 37382660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
    Jansen MH; van Vuurden DG; Vandertop WP; Kaspers GJ
    Cancer Treat Rev; 2012 Feb; 38(1):27-35. PubMed ID: 21764221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options in childhood pontine gliomas.
    Wagner S; Warmuth-Metz M; Emser A; Gnekow AK; Sträter R; Rutkowski S; Jorch N; Schmid HJ; Berthold F; Graf N; Kortmann RD; Pietsch T; Sörensen N; Peters O; Wolff JE
    J Neurooncol; 2006 Sep; 79(3):281-7. PubMed ID: 16598416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas.
    Goodwin CR; Xu R; Iyer R; Sankey EW; Liu A; Abu-Bonsrah N; Sarabia-Estrada R; Frazier JL; Sciubba DM; Jallo GI
    Clin Neurol Neurosurg; 2016 Mar; 142():120-127. PubMed ID: 26849840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG).
    Gwak HS; Park HJ
    Crit Rev Oncol Hematol; 2017 Dec; 120():111-119. PubMed ID: 29198324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
    Hashizume R
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.